PeckGLDiGiovannaJJ. Retinoids. In: FitzpatrickTBEisenAZWolfKFreedbergIMAustenKF, eds. Dermatology in general medicine. New York: McGraw-Hill, 1993:2883–96.
2.
PurtonLEBernsteinIDCollinsSJ. All-trans retinoic acid delays the differentiation of primitive hematopoietic precursors (lin-c-kit+Sco-1+) while enhancing the terminal maturation of committed granulocyte/ monocyte progenitors. Blood1999;94:483–95.
3.
RaifeTJMcArthurJPetersCKiskerCTLentzSR. Remission after 13-cis retinoic acid in thrombotic thrombocytopenic purpura (letter). Lancet1998;352:454–5.
4.
HesdorfferCSWeltmanMDRaftopoulosHMendelowBBezwodaWR. Thrombocytopenia caused by isotretinoin (letter). S Afr Med J1986;70:705–6.
5.
PerrinMCBlanchetJPMouchiroudG. Modulation of human and mouse erythropoiesis by thyroid hormone and retinoic acid: Evidence for specific effects at different steps of the erythroid pathway. Hematol Cell Ther1997;39:19–26.
6.
DouerDKoefflerHP. Retinoic acid enhances growth of human early erythroid progenitor cells in vitro. J Clin Invest1982;69:1039–41.
7.
PurtonLEBernsteinIDCollinsSJ. All-trans retinoic acid enhances the long-term repopulating activity of cultured hematopoietic stem cells. Blood2000;95:470–7.
8.
NaranjoCABustoUSellersEMSandorPRuizIRobertsEAA method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther1981;30:239–45.
9.
MarcusRCoulstonM. Fat-soluble vitamins. In: HardmanJGLimbirdLEMolinoffPBRuddonRW, eds. Goodman and Gilman's the pharmacological basis of therapeutics. 9th ed.New York: McGraw-Hill, 1996:1573–8.
